Skip to main content
. Author manuscript; available in PMC: 2009 Jun 24.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1096–1103. doi: 10.1158/1055-9965.EPI-08-0201

Figure 1.

Figure 1

(A) Recurrence-free survival curves for patients with symptom-detected breast cancer compared to those of patients with screen-detected breast cancer, adjusting for the tumor stage at diagnosis. (B) Recurrence-free survival curves for patients with symptom-detected breast cancer compared to those of patients with screen-detected breast cancer, after controlling for tumor stage and estrogen receptor status. RR is relative risk. 95% confidence interval of RR was given in the parenthesis.